NeoPharm CO. LTD - Asset Resilience Ratio

Latest as of September 2025: 53.07%

NeoPharm CO. LTD (092730) has an Asset Resilience Ratio of 53.07% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read NeoPharm CO. LTD total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

₩110.05 Billion

≈ $74.58 Million USD Cash + Short-term Investments

Total Assets

₩207.38 Billion

≈ $140.54 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2012–2024)

This chart shows how NeoPharm CO. LTD's Asset Resilience Ratio has changed over time. See shareholders equity of NeoPharm CO. LTD for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down NeoPharm CO. LTD's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see NeoPharm CO. LTD market cap and net worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩110.05 Billion	53.07%
Total Liquid Assets	₩110.05 Billion	53.07%

Asset Resilience Insights

Very High Liquidity: NeoPharm CO. LTD maintains exceptional liquid asset reserves at 53.07% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

NeoPharm CO. LTD Industry Peers by Asset Resilience Ratio

Compare NeoPharm CO. LTD's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
HYUNDAI BIOLAND Co.Ltd KQ:052260	Personal & Household Products & Services	0.30%
Globon Co. Ltd KQ:019660	Personal & Household Products & Services	19.06%
Gentrogroup Co. Ltd. KQ:083660	Personal & Household Products & Services	19.19%

Annual Asset Resilience Ratio for NeoPharm CO. LTD (2012–2024)

The table below shows the annual Asset Resilience Ratio data for NeoPharm CO. LTD.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	56.27%	₩108.29 Billion ≈ $73.39 Million	₩192.44 Billion ≈ $130.41 Million	-0.14pp
2023-12-31	56.41%	₩100.11 Billion ≈ $67.84 Million	₩177.46 Billion ≈ $120.26 Million	-16.64pp
2022-12-31	73.05%	₩113.49 Billion ≈ $76.91 Million	₩155.35 Billion ≈ $105.28 Million	-0.20pp
2021-12-31	73.25%	₩105.05 Billion ≈ $71.19 Million	₩143.41 Billion ≈ $97.19 Million	+0.92pp
2020-12-31	72.33%	₩96.18 Billion ≈ $65.18 Million	₩132.98 Billion ≈ $90.12 Million	+2.66pp
2019-12-31	69.67%	₩85.51 Billion ≈ $57.95 Million	₩122.74 Billion ≈ $83.18 Million	+11.50pp
2018-12-31	58.17%	₩42.42 Billion ≈ $28.75 Million	₩72.93 Billion ≈ $49.42 Million	+2.73pp
2017-12-31	55.43%	₩31.43 Billion ≈ $21.30 Million	₩56.69 Billion ≈ $38.42 Million	+5.74pp
2016-12-31	49.70%	₩23.11 Billion ≈ $15.66 Million	₩46.51 Billion ≈ $31.52 Million	+25.38pp
2012-12-31	24.32%	₩8.30 Billion ≈ $5.63 Million	₩34.14 Billion ≈ $23.14 Million	--

pp = percentage points

About NeoPharm CO. LTD

KQ:092730 Korea Personal & Household Products & Services

Market Cap

$110.44 Million

₩162.97 Billion KRW

Market Cap Rank

#18792 Global

#976 in Korea

Share Price

₩20400.00

Change (1 day)

-7.90%

52-Week Range

₩13280.00 - ₩22150.00

All Time High

₩27383.15